IL-6 as a Potential Sensitive Serum Biomarker in Stevens-johnson Syndrome/Toxic Epidermal Necrolysis: Two Case Reports
Although different cytokines and serum markers have been proposed for the diagnosis of severe cutaneous adverse reactions (SCAR) like SJS/TEN, they are still experimental. We were the first to use IL-6 measurement as a helpful biomarker in the diagnosis and therapeutic management.
Authors
- E. Nettis
- Gianfranco Calogiuri (ORCID: https://orcid.org/0000-0003-0007-3755)
- Angela Filoni (ORCID: https://orcid.org/0000-0002-9790-5361)
- Caterina Foti (ORCID: https://orcid.org/0000-0002-3977-4295)
- Emiliano Sordi
- Lucia Pietroleonardo
- Francesca Petrachi
- Ester Sofia Congedo
- Maurizio Congedo
- Gianluigi Conte
Institutions
- Università Campus Bio-Medico (IT)
- Ospedale Vito Fazzi (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Recent Advances in Inflammation & Allergy Drug Discovery
- Published
- 2026-01-02
- DOI
- https://doi.org/10.2174/0127722708411671251129222134
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00